Salmonella Agona outbreak: infant formula recall to reduce risk to public health
The widespread recall of several infant formula products made by a French processing company is likely to significantly reduce the risk of infants being infected by Salmonella Agona, according to the risk assessment published today by ECDC and the European Food Safety Authority (EFSA). However, as long as there are potentially contaminated products circulating, new cases may still be detected.
Measles in the EU/EEA: current outbreaks, latest data and trends – January 2018
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 49 deaths due to measles have been reported in the EU,
Salmonella Agona outbreak associated with infant formula milk
On 6 December 2017, France reported an outbreak of Salmonella Agona in infants <1 years of age linked to consumption of infant milk formula based on an epidemiological investigation. Different brands of infant formulas from the same producer in France and distributed to different countries inside and outside the EU were implicated as the vehicle of infection in this outbreak.
European laboratories move forward towards stronger epidemic readiness for infectious disease threats.
The latest EULabCap data on assessing the public health laboratory capacities among 30 EU and EEA countries in 2016 reveal continuous improvement in reducing inequalities, with ten more countries reaching fair to high capability levels over the 4 years of monitoring.
Measles in the EU/EEA: current outbreaks, latest data and trends – December 2017
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU.
Expert opinion on meningococcal B vaccine – information and suggestions to EU/EEA countries
The ECDC expert opinion provides information on the burden of serogroup B invasive meningococcal disease in the EU/EEA, includes general considerations for 4CMenB introduction such as vaccine immunogenicity, safety, cost-effectiveness, ease of implementation and areas for country collaboration, and highlights different options for vaccine introduction.
Because it’s best to know: start of European HIV-Hepatitis testing week
An estimated 122 000 people living with HIV across Europe are not aware of their HIV infection and a large number out of the estimated 9 million Europeans that are affected by chronic hepatitis B or C have not yet been tested or diagnosed. ECDC welcomes the efforts of European HIV-Hepatitis Testing Week which starts today.
Combined resistance to multiple antibiotics: a growing problem in the EU
On the occasion of the 10th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance, as well as its guidance on prevention and control of carbapenem-resistant Enterobacter iaceae (CRE). In 2016, combined resistance to several antibiotic groups continued to increase for Escherichia coli and Acinetobacter species. This situation is of great concern as patients infected with these multidrugresistant bacteria have very limited treatment options.
It’s everyone’s responsibility to #KeepAntibioticsWorking. Join the social media campaign!
On the occasion of the 10th European Antibiotic Awareness Day (EAAD), which will be celebrated on 18 November 2017, the European Centre for Disease Prevention and Control (ECDC) is launching a social media campaign called #KeepAntibioticsWorking.